|
|
Volumn 90, Issue 9, 1998, Pages 642-644
|
|
Gastrointestinal carcinoma antigen GA733: target for immunodestruction and potential modifier of invasiveness and chemoresponsiveness.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL ADHESION MOLECULE;
MONOCLONAL ANTIBODY;
TUMOR ANTIGEN;
TUMOR ASSOCIATED ANTIGEN GA733;
TUMOR MARKER;
TUMOR-ASSOCIATED ANTIGEN GA733;
ANIMAL;
CANCER INVASION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
GASTROINTESTINAL TUMOR;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METABOLISM;
METHODOLOGY;
NOTE;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, NEOPLASM;
CELL ADHESION MOLECULES;
CLINICAL TRIALS, PHASE II;
GASTROINTESTINAL NEOPLASMS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOTHERAPY;
NEOPLASM INVASIVENESS;
RANDOMIZED CONTROLLED TRIALS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0032490067
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/90.9.642 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
